Leonard Braden Michael

Outset Medical, Inc. ยท 10% Owner

Leonard Braden Michael is listed in public filings as 10 percent owner. This Leonard Braden Michael insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Outset Medical, Inc. (OM), Aclaris Therapeutics, Inc. (ACRS), Adverum Biotechnologies, Inc. (ADVM), Astrotech Corporation (ASTC), and AN2 Therapeutics, Inc. (ANTX). Investors use Leonard Braden Michael's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Outset Medical, Inc.OM$13M2.5M sharesOtherMay 15, 2026$1.6M323k shares$5.00--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Outset Medical, Inc.OM$11M2.2M sharesOtherMay 11, 2026$484.5K96.9k shares$5.00--
Outset Medical, Inc.OM$10M2.1M sharesOtherMay 8, 2026$988.0K197.6k shares$5.00--
Aclaris Therapeutics, Inc.ACRS$63M14M sharesSellApr 23, 2026$1.4M300k shares$4.53--
Adverum Biotechnologies, Inc.ADVM$8.2M2M sharesSellDec 4, 2025$2.2M524.6k shares$4.19--
Adverum Biotechnologies, Inc.ADVM$10M2.4M sharesSellDec 3, 2025$929.6K222.9k shares$4.17--
Adverum Biotechnologies, Inc.ADVM$11M2.7M sharesSellDec 2, 2025$218.2K52k shares$4.20--
Adverum Biotechnologies, Inc.ADVM$12M2.8M sharesSellDec 1, 2025$1.3M300k shares$4.20--
Astrotech CorporationASTC$0220.4k sharesSellOct 3, 2025$1.6M220.4k shares$7.13--
Astrotech CorporationASTC$09.2k sharesSellOct 3, 2025$53.4K9.2k shares$5.83--
AN2 Therapeutics, Inc.ANTX$3.3M3.2M sharesSellMay 30, 2025$429.3K425k shares$1.01--
AN2 Therapeutics, Inc.ANTX$3.3M3.2M sharesSellMay 30, 2025$7.2K7k shares$1.03--
AN2 Therapeutics, Inc.ANTX$4.3M3.7M sharesSellMay 28, 2025$2.3M2M shares$1.16--
AN2 Therapeutics, Inc.ANTX$3.3M3M sharesSellMay 28, 2025$218.0K200k shares$1.09--
AN2 Therapeutics, Inc.ANTX$4.2M3.6M sharesSellMay 28, 2025$116.0K100k shares$1.16--
Adverum Biotechnologies, Inc.ADVM$571k191.8k sharesBuyApr 23, 2025$148.9K50k shares$2.98--
Adverum Biotechnologies, Inc.ADVM$9.2M3.1M sharesBuyApr 22, 2025$900.0K300k shares$3.00--
Adverum Biotechnologies, Inc.ADVM$11M2.8M sharesBuyApr 2, 2025$61.4K15.2k shares$4.04--
Adverum Biotechnologies, Inc.ADVM$12M2.7M sharesBuyMar 31, 2025$85.7K19.6k shares$4.38--
Adverum Biotechnologies, Inc.ADVM$736k141.8k sharesBuyMar 27, 2025$86.1K16.6k shares$5.19--
Adverum Biotechnologies, Inc.ADVM$736k141.8k sharesBuyMar 27, 2025$86.1K16.6k shares$5.19--
Adverum Biotechnologies, Inc.ADVM$631k125.2k sharesBuyMar 26, 2025$102.8K20.4k shares$5.04--
Adverum Biotechnologies, Inc.ADVM$15M2.7M sharesBuyMar 20, 2025$171.8K30.6k shares$5.61--
Adverum Biotechnologies, Inc.ADVM$13M2.7M sharesBuyMar 19, 2025$123.4K25k shares$4.94--
Adverum Biotechnologies, Inc.ADVM$13M2.7M sharesBuyMar 18, 2025$209.6K44.3k shares$4.73--
Adverum Biotechnologies, Inc.ADVM$12M2.6M sharesBuyMar 18, 2025$82.8K18k shares$4.60--
Adverum Biotechnologies, Inc.ADVM$12M2.6M sharesBuyFeb 28, 2025$391.0K85.1k shares$4.60--
Adverum Biotechnologies, Inc.ADVM$11M2.5M sharesBuyFeb 27, 2025$387.1K86.8k shares$4.46--
Adverum Biotechnologies, Inc.ADVM$9.8M2.4M sharesBuyFeb 26, 2025$661.0K164.9k shares$4.01--
OnKure Therapeutics, Inc.OKUR--102.1k sharesOtherOct 7, 2024Disclosure amount unavailable102.1k shares----
OnKure Therapeutics, Inc.OKUR--345.7k sharesOtherOct 7, 2024Disclosure amount unavailable345.7k shares----
Talis Biomedical CorporationTLIS$369k248.7k sharesBuySep 6, 2024$37.1K25k shares$1.48--
Talis Biomedical CorporationTLIS$313k223.7k sharesBuySep 5, 2024$7.1K5.1k shares$1.40--
Talis Biomedical CorporationTLIS$874k218.6k sharesBuySep 3, 2024$2.0K500 shares$4.00--
Talis Biomedical CorporationTLIS$929k218.6k sharesBuyAug 30, 2024$642151 shares$4.25--
Talis Biomedical CorporationTLIS$864k218k sharesBuyAug 28, 2024$4.8K1.2k shares$3.96--
Talis Biomedical CorporationTLIS$845k216.7k sharesBuyAug 26, 2024$51.3K13.2k shares$3.90--
AN2 Therapeutics, Inc.ANTX$6.0M5.7M sharesBuyAug 14, 2024$1.6M1.5M shares$1.04--
Aclaris Therapeutics, Inc.ACRS$18M14.3M sharesBuyAug 5, 2024$256.4K206k shares$1.24--
Aclaris Therapeutics, Inc.ACRS$18M14M sharesBuyAug 2, 2024$216.4K167.5k shares$1.29--
Aclaris Therapeutics, Inc.ACRS$18M13.9M sharesBuyJul 31, 2024$132.6K100k shares$1.33--
Adverum Biotechnologies, Inc.ADVM$16M2.3M sharesBuyJul 30, 2024$613.5K85.8k shares$7.15--
Aclaris Therapeutics, Inc.ACRS$18M13.8M sharesBuyJul 30, 2024$226.4K173.7k shares$1.30--
Aclaris Therapeutics, Inc.ACRS$18M13.6M sharesBuyJul 22, 2024$23.6K17.7k shares$1.33--
Aclaris Therapeutics, Inc.ACRS$18M13.6M sharesBuyJul 19, 2024$8.7K6.7k shares$1.30--
Adverum Biotechnologies, Inc.ADVM$20M2.2M sharesBuyJul 18, 2024$735.7K80.7k shares$9.11--
Aclaris Therapeutics, Inc.ACRS$18M13.6M sharesBuyJul 18, 2024$169.6K130.3k shares$1.30--
Adverum Biotechnologies, Inc.ADVM$16M2.1M sharesBuyJul 17, 2024$1.0M135.5k shares$7.75--
Aclaris Therapeutics, Inc.ACRS$15M13.4M sharesBuyJul 5, 2024$141.3K123k shares$1.15--
Aclaris Therapeutics, Inc.ACRS$15M13.3M sharesBuyJul 3, 2024$166.1K143.3k shares$1.16--
Aclaris Therapeutics, Inc.ACRS$15M13.2M sharesBuyJul 2, 2024$98.5K86.1k shares$1.14--
Aclaris Therapeutics, Inc.ACRS$15M13.1M sharesBuyJul 1, 2024$122.2K107.4k shares$1.14--
Aclaris Therapeutics, Inc.ACRS$14M12.6M sharesBuyJun 28, 2024$896.6K801k shares$1.12--
Aclaris Therapeutics, Inc.ACRS$15M13M sharesBuyJun 28, 2024$452.0K400k shares$1.13--
Aclaris Therapeutics, Inc.ACRS$14M11.8M sharesBuyJun 27, 2024$271.3K235k shares$1.15--
Tectonic Therapeutic, Inc.TECX--33.3k sharesOtherJun 20, 2024Disclosure amount unavailable33.3k shares----
Tectonic Therapeutic, Inc.TECX--400.4k sharesOtherJun 20, 2024Disclosure amount unavailable400.4k shares----
Aclaris Therapeutics, Inc.ACRS$13M11.6M sharesBuyJun 18, 2024$56.5K50k shares$1.13--
Aclaris Therapeutics, Inc.ACRS$13M11.5M sharesBuyJun 17, 2024$169.5K150k shares$1.13--
Aclaris Therapeutics, Inc.ACRS$13M11.4M sharesBuyJun 14, 2024$402.2K345k shares$1.17--
Aclaris Therapeutics, Inc.ACRS$13M11M sharesBuyJun 13, 2024$575.0K500k shares$1.15--
Aclaris Therapeutics, Inc.ACRS$12M10.5M sharesBuyJun 13, 2024$32.8K28.6k shares$1.14--
Aclaris Therapeutics, Inc.ACRS$12M10.5M sharesBuyJun 12, 2024$94.1K82.6k shares$1.14--
Aclaris Therapeutics, Inc.ACRS$11M10.4M sharesBuyJun 11, 2024$1.1M1M shares$1.08--